T1	Chemical	31 51	adding the multidrug
T2	Gene_or_protein	31 89	adding the multidrug resistance gene-1 ( MDR-1 ) modulator
T3	Chemical	31 178	adding the multidrug resistance gene-1 ( MDR-1 ) modulator valspodar ( PSC 833 ; Novartis Pharmaceuticals , Hanover , NJ ) to chemotherapy provided
T4	Pharmacodynamic_phenotype	179 207	clinical benefit to patients
T5	Disease	223 251	acute myeloid leukemia ( AML
T6	Disease	268 298	myelodysplastic syndrome ( MDS
R1	influences	Arg1:T1	Arg2:T2
R2	influences	Arg1:T1	Arg2:T3
R3	causes	Arg1:T1	Arg2:T4
R4	treats	Arg1:T1	Arg2:T5
R5	treats	Arg1:T1	Arg2:T6
R6	influences	Arg1:T2	Arg2:T1
R7	influences	Arg1:T2	Arg2:T3
R8	causes	Arg1:T2	Arg2:T4
R9	treats	Arg1:T2	Arg2:T5
R10	treats	Arg1:T2	Arg2:T6
R11	influences	Arg1:T3	Arg2:T1
R12	influences	Arg1:T3	Arg2:T2
R13	causes	Arg1:T3	Arg2:T4
R14	treats	Arg1:T3	Arg2:T5
R15	treats	Arg1:T3	Arg2:T6
R16	influences	Arg1:T4	Arg2:T1
R17	influences	Arg1:T4	Arg2:T2
R18	influences	Arg1:T4	Arg2:T3
R19	treats	Arg1:T4	Arg2:T5
R20	treats	Arg1:T4	Arg2:T6
R21	isAssociatedWith	Arg1:T5	Arg2:T1
R22	influences	Arg1:T5	Arg2:T2
R23	influences	Arg1:T5	Arg2:T3
R24	isAssociatedWith	Arg1:T5	Arg2:T4
R25	treats	Arg1:T5	Arg2:T6
R26	isAssociatedWith	Arg1:T6	Arg2:T1
R27	influences	Arg1:T6	Arg2:T2
R28	influences	Arg1:T6	Arg2:T3
R29	isAssociatedWith	Arg1:T6	Arg2:T4
R30	treats	Arg1:T6	Arg2:T5
